California State Teachers Retirement System (CalSTRS)
STOK icon

California State Teachers Retirement System (CalSTRS)’s Stoke Therapeutics STOK Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
50,138
-1,468
-3% -$47.1K ﹤0.01% 1691
2026
Q1 		$1.68M Buy
51,606
+14,479
+39% +$475K ﹤0.01% 1623
2025
Q4 		$1.18M Buy
37,127
+5,057
+16% +$152K ﹤0.01% 1722
2025
Q3 		$754K Buy
32,070
+2
+0% +$34 ﹤0.01% 1908
2025
Q2 		$364K Hold
32,068
– – ﹤0.01% 2168
2025
Q1 		$213K Hold
32,068
– – ﹤0.01% 2298
2024
Q4 		$354K Buy
32,068
+4,468
+16% +$54.9K ﹤0.01% 2253
2024
Q3 		$339K Sell
27,600
-5,487
-17% -$77.7K ﹤0.01% 2269
2024
Q2 		$447K Buy
33,087
+30,284
+1,080% +$409K ﹤0.01% 2142
2024
Q1 		$37.8K Sell
2,803
-1,737
-38% -$10.5K ﹤0.01% 2538
2023
Q4 		$23.9K Sell
4,540
-19,111
-81% -$81.7K ﹤0.01% 2860
2023
Q3 		$93.2K Sell
23,651
-3,011
-11% -$19.8K ﹤0.01% 2588
2023
Q2 		$283K Buy
26,662
+4,498
+20% +$47.9K ﹤0.01% 2485
2023
Q1 		$185K Sell
22,164
-755
-3% -$6.81K ﹤0.01% 2586
2022
Q4 		$212K Buy
22,919
+569
+3% +$5.92K ﹤0.01% 2612
2022
Q3 		$287K Buy
22,350
+294
+1% +$4.68K ﹤0.01% 2544
2022
Q2 		$291K Buy
22,056
+2,875
+15% +$43.7K ﹤0.01% 2574
2022
Q1 		$404K Sell
19,181
-2,132
-10% -$42.7K ﹤0.01% 2468
2021
Q4 		$511K Buy
21,313
+483
+2% +$11.5K ﹤0.01% 2501
2021
Q3 		$530K Sell
20,830
-5,507
-21% -$154K ﹤0.01% 2448
2021
Q2 		$887K Buy
26,337
+5,874
+29% +$208K ﹤0.01% 2283
2021
Q1 		$795K Buy
20,463
+1,699
+9% +$96.7K ﹤0.01% 2281
2020
Q4 		$1.16M Buy
18,764
+344
+2% +$15.8K ﹤0.01% 1944
2020
Q3 		$617K Hold
18,420
– – ﹤0.01% 2153
2020
Q2 		$439K Sell
18,420
-7,433
-29% -$176K ﹤0.01% 2317
2020
Q1 		$592K Buy
25,853
+11,589
+81% +$286K ﹤0.01% 1977
2019
Q4 		$404K Hold
14,264
– – ﹤0.01% 2458
2019
Q3 		$307K Buy
+14,264
New +$398K ﹤0.01% 2591

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s STOK Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Stoke Therapeutics (STOK) stake by 2.8% in Q2 2026, selling an estimated $47.1K and leaving 50,138 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

California State Teachers Retirement System (CalSTRS) first reported a position in STOK in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.68M in Q1 2026. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 50,138 shares of Stoke Therapeutics worth $1.64M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,468 Stoke Therapeutics shares in Q2 2026, an estimated $47.1K.
  • Stoke Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1691 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Stoke Therapeutics in Q3 2019 and has held it in 28 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Stoke Therapeutics position peaked at $1.68M in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.